X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (226) 226
Journal Article (76) 76
Publication (8) 8
Conference Proceeding (6) 6
Newspaper Article (6) 6
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (201) 201
metallurgy (201) 201
biochemistry (199) 199
beer (197) 197
enzymology (197) 197
microbiology (197) 197
mutation or genetic engineering (197) 197
spirits (197) 197
vinegar (197) 197
wine (197) 197
human necessities (195) 195
hygiene (195) 195
medical or veterinary science (195) 195
preparations for medical, dental, or toilet purposes (193) 193
compositions thereof (192) 192
culture media (192) 192
microorganisms or enzymes (192) 192
propagating, preserving or maintaining microorganisms (192) 192
organic chemistry (141) 141
peptides (139) 139
specific therapeutic activity of chemical compounds ormedicinal preparations (55) 55
index medicus (42) 42
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (30) 30
derivatives thereof (26) 26
nucleic acids (26) 26
nucleosides (26) 26
nucleotides (26) 26
sugars (26) 26
animals (24) 24
humans (23) 23
blasting (22) 22
heating (22) 22
indexing scheme associated with subclasses f21k, f21l, f21sand f21v, relating to theform or the kind of the light sources or of the colour of thelight emitted (22) 22
lighting (22) 22
mechanical engineering (22) 22
weapons (22) 22
gene therapy (20) 20
medicine, research & experimental (19) 19
mice (19) 19
genetics & heredity (17) 17
non-portable lighting devices (16) 16
systems thereof (16) 16
vehicle lighting devices specially adapted for vehicleexteriors (16) 16
biotechnology & applied microbiology (15) 15
electric heating (13) 13
electric lighting not otherwise provided for (13) 13
electric techniques not otherwise provided for (13) 13
electricity (13) 13
light sources not otherwise provided for (13) 13
light sources using charges of combustible material (13) 13
light sources using electrochemiluminescence (13) 13
light sources using semiconductor devices as light-generatingelements (13) 13
non-electric light sources using luminescence (13) 13
genetics (12) 12
gene expression (11) 11
adenoviridae - genetics (10) 10
functional features or details of lighting devices or systemsthereof (10) 10
genetic vectors (10) 10
male (10) 10
structural combinations of lighting devices with otherarticles, not otherwise provided for (10) 10
female (9) 9
molecular biology (9) 9
optics (9) 9
pharmacology (9) 9
physics (9) 9
dependovirus - genetics (8) 8
drug discovery (8) 8
health aspects (8) 8
macular degeneration (8) 8
mice, inbred c57bl (8) 8
molecular medicine (8) 8
mutation (8) 8
virology (8) 8
enzymes (7) 7
gene-therapy (7) 7
genetic therapy (7) 7
immune-responses (7) 7
research (7) 7
apoptosis (6) 6
care and treatment (6) 6
endothelial growth-factor (6) 6
genetic vectors - genetics (6) 6
molecular sequence data (6) 6
retina (6) 6
usage (6) 6
abridged index medicus (5) 5
adenovirus e3 proteins - genetics (5) 5
article (5) 5
cells, cultured (5) 5
excitation (5) 5
expression (5) 5
eye diseases (5) 5
genetic aspects (5) 5
genetic structures (5) 5
genetic therapy - methods (5) 5
mice, inbred balb c (5) 5
optical elements, systems, or apparatus (5) 5
sense organs (5) 5
viruses (5) 5
age (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (285) 285
French (83) 83
German (34) 34
Spanish (21) 21
Chinese (20) 20
Portuguese (10) 10
Korean (6) 6
Danish (3) 3
Russian (2) 2
Greek (1) 1
Hungarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 50 - 61
Summary Background Long-term intraocular injections of vascular endothelial growth factor (VEGF)-neutralising proteins can preserve central vision in many... 
Internal Medicine | RETINAL NEOVASCULARIZATION | EPITHELIUM-DERIVED FACTOR | MEDICINE, GENERAL & INTERNAL | INHIBITION | VEGF | RANDOMIZED CLINICAL-TRIAL | GENE-THERAPY | CHOROIDAL NEOVASCULARIZATION | VECTORS | RANIBIZUMAB | SFLT-1 | Macular Degeneration - diagnostic imaging | Recombinant Fusion Proteins - biosynthesis | Parvovirinae - genetics | Angiogenesis Inhibitors - genetics | Choroidal Neovascularization - diagnostic imaging | Genetic Vectors - administration & dosage | Intravitreal Injections | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Humans | Middle Aged | Choroidal Neovascularization - therapy | Male | Visual Acuity | Choroidal Neovascularization - physiopathology | Angiogenesis Inhibitors - biosynthesis | Macular Degeneration - therapy | Aged, 80 and over | Recombinant Fusion Proteins - genetics | Female | Aged | Recombinant Fusion Proteins - administration & dosage | Genetic Therapy - adverse effects | Genetic Therapy - methods | Macular degeneration | Proteins | Medical colleges | Care and treatment | Physiological aspects | Ophthalmology | Vascular endothelial growth factor | Consulting services | Endothelial growth factors | Aqueous humour | Antibodies | Clinical trials | Retina | Visual acuity | Genomes | Injection | Permeability | Dosage | Patients | Fever | Visual perception | Acuity | Eye | Studies | Vision | Photoreceptors | Degeneration | Safety | Gene therapy | Age | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10108, pp. 2140 - 2140
To mitigate risk of vision loss from AAV2-sFLT01 or withholding of standard care, only patients with subretinal fibrosis and hence limited visual potential... 
Choroidal Neovascularization | Genetic Therapy | Humans | Macular Degeneration | Fees & charges | Permeability | Gene therapy | Patients | Vascular endothelial growth factor | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Molecular Therapy, ISSN 1525-0016, 05/2016, Volume 24, pp. S131 - S132
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, pp. e95900 - e95900
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2010, Volume 107, Issue 44, pp. 18961 - 18966
Journal Article
International Journal of Pharmaceutical Sciences and Research, ISSN 0975-8232, 10/2018, Volume 9, Issue 10, p. 4109
Tuberculosis (TB) is one of the second most deadly infectious disease which causes for morbidity as well as mortality. This communicable infectious disease is... 
Complications and side effects | Care and treatment | Usage | Tuberculosis | Antitubercular agents | Dosage and administration | Research | Drug resistance | Nanotechnology
Journal Article
Molecular Therapy - Methods & Clinical Development, ISSN 2329-0501, 06/2018, Volume 9, pp. 33 - 46
The generation of clinical good manufacturing practices (GMP)-grade adeno-associated virus (AAV) vectors requires purification strategies that support the... 
epitope swapping | analytical ultracentrifugation | AAV purification | MEDICINE, RESEARCH & EXPERIMENTAL | ADENOASSOCIATED VIRAL VECTORS | GENE-THERAPY | CHROMATOGRAPHY | LEBERS CONGENITAL AMAUROSIS | ADENOVIRUS | TITER | HEMOPHILIA
Journal Article
Diabetes, ISSN 0012-1797, 02/2008, Volume 57, Issue 2, pp. 405 - 414
Journal Article
Journal Article
by Dicker, Daniel and Nguyen, Trang Huyen and Nguyen, Ha Thu and Nguyen, Grant and Nguyen, Long Hoang and Nguyen, Huong Thanh and Nguyen, Michele and Abate, Kalkidan Hassen and Abate, Degu and Abay, Solomon M and Abbafati, Cristiana and Abbasi, Nooshin and Abbastabar, Hedayat and Abd-Allah, Foad and Abdela, Jemal and Abdelalim, Ahmed and Abdel-Rahman, Omar and Abdi, Alireza and Abdollahpour, Ibrahim and Abdulkader, Rizwan Suliankatchi and Abdurahman, Ahmed Abdulahi and Abebe, Haftom Temesgen and Abebe, Zegeye and Abebe, Molla and Abebo, Teshome Abuka and Aboyans, Victor and Abraha, Haftom Niguse and Abrham, Aklilu Roba and Abu-Raddad, Laith Jamal and Abu-Rmeileh, Niveen ME and Accrombessi, Manfred Mario Kokou and Acharya, Pawan and Adebayo, Oladimeji M and Adedeji, Isaac Akinkunmi and Adedoyin, Rufus Adesoji and Adekanmbi, Victor and Adetokunboh, Olatunji O and Adhena, Beyene Meressa and Adhikari, Tara Ballav and Adib, Mina G and Adou, Arsène Kouablan and Adsuar, Jose C and Afarideh, Mohsen and Afshin, Ashkan and Agarwal, Gina and Aggarwal, Rakesh and Aghayan, Sargis Aghasi and Agrawal, Sutapa and Agrawal, Anurag and Ahmadi, Mehdi and Ahmadi, Alireza and Ahmadieh, Hamid and Ahmed, Muktar Beshir and Ahmed, Mohamed Lemine Cheikh brahim and Ahmed, Sayem and Aichour, Ibtihel and Aichour, Miloud Taki Eddine and Aichour, Amani Nidhal and Akanda, Ali S and Akbari, Mohammad Esmaeil and Akibu, Mohammed and Akinyemi, Rufus Olusola and Akinyemiju, Tomi and Akseer, Nadia and Alahdab, Fares and Al-Aly, Ziyad and Alam, Khurshid and Alebel, Animut and Aleman, Alicia V and Alene, Kefyalew Addis and Al-Eyadhy, Ayman and Ali, Raghib and Alijanzadeh, Mehran and Alizadeh-Navaei, Reza and Aljunid, Syed Mohamed and Alkerwi, Ala'a and Alla, François and Allebeck, Peter and Allen, Christine A and Alonso, Jordi and Al-Raddadi, Rajaa M and Alsharif, Ubai and Altirkawi, Khalid and Alvis-Guzman, Nelson and Amare, Azmeraw T and Amini, Erfan and Ammar, Walid and Amoako, Yaw Ampem and Anber, Nahla Hamed and Andrei, Catalina Liliana and Androudi, Sofia and Animut, Megbaru Debalkie and Anjomshoa, Mina and Anlay, Degefaye Zelalem and Ansari, Hossein and Ansariadi, Ansariadi and Ansha, Mustafa Geleto and Antonio, Carl Abelardo T and Appiah, Seth Christopher Yaw and Aremu, Olatunde and ... and GBD 2017 Mortality Collaborators and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Medicinsk vetenskap
The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10159, pp. 1684 - 1735